<SEC-DOCUMENT>0001104659-23-091317-index.html : 20230814 <SEC-HEADER>0001104659-23-091317.hdr.sgml : 20230814 <ACCEPTANCE-DATETIME>20230814160806 ACCESSION NUMBER: 0001104659-23-091317 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 EFFECTIVENESS DATE: 20230814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 231170022 BUSINESS ADDRESS: STREET 1: 25-28 NORTH WALL QUAY CITY: DUBLIN STATE: L2 ZIP: D01 H104 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 414 COMMERCE DRIVE STREET 2: STE 120 CITY: FORT WASHINGTON STATE: PA ZIP: 19034 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>NT 10-Q <SEQUENCE>1 <FILENAME>tm2323727d1_nt10q.htm <DESCRIPTION>NT 10-Q <TEXT> Document 1 - file: tm2323727d1_nt10q.htm
</DOCUMENT> </SEC-DOCUMENT>